Scientists Find Way to Reverse Chemo Resistance in Pancreatic Cancer Patients
By Dennis Thompson HealthDay Reporter
MONDAY, July 8, 2024 -- Pancreatic cancer is particularly aggressive and difficult to treat, partly because it’s often resistant to chemotherapy.
Researchers now think they know why chemo struggles to work against pancreatic cancer – and how to reverse that resistance.
It turns out that the physical stiffness of the tissue around the cancer cells makes chemo less effective, researchers reported July 4 in the journal Nature Materials.
“We found that stiffer tissue can cause pancreatic cancer cells to become resistant to chemotherapy, while softer tissue made the cancer cells more responsive to chemotherapy,” senior researcher Sarah Heilshorn, a professor of materials science and engineering at Stanford University, said in a news release.
“These results suggest an exciting new direction for future drug development to help overcome chemoresistance, which is a major clinical challenge in pancreatic cancer,” she added.
The study focused on pancreatic ductal adenocarcinoma, which accounts for 90% of pancreatic cancer cases. This form of cancer starts in the cells lining the ducts of the pancreas.
In these cancers, the tissue becomes notably stiffer, acting as a physical block that prevents chemo from reaching cancer cells, researchers said.
To figure out what is happening, researchers designed tissue in the lab that mimicked the properties of both pancreatic tumors and healthy pancreas tissues. They then used this tissue to culture cells drawn from pancreatic cancer patients.
“We created a designer matrix that would allow us to test the idea that these cancerous cells might be responding to the chemical signals and mechanical properties in the matrix around them,” Heilshorn said.
The researchers found that two things caused pancreatic cancer to become resistant to chemo – stiffer tissue and high amounts of hyaluronic acid, a substance that helps stiffen the tissue.
Hyaluronic acid interacts with cellular tissue through a receptor called CD44. Researchers found they could make tissue softer and more responsive to chemo if they blocked the CD44 receptor.
“We can revert the cells back to a state where they are sensitive to chemotherapy,” Heilshorn said. “This suggests that if we can disrupt the stiffness signaling that’s happening through the CD44 receptor, we could make patients’ pancreatic cancer treatable by normal chemotherapy.”
The research team continues to investigate the CD44 receptor, as well as the chain of events that follows after the receptor is activated in a cancerous cell.
The researchers are also working to improve their cell culture model, so that it can be used to predict how chemo and other cancer therapies will work in specific patients.
“When we design chemotherapies, we should be testing our cultures in matrices that are relevant to a patient,” Heilshorn said. “Because it matters – the way cells respond to drugs depends on the matrix that’s around them.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-07-09 05:15
Read more
- Pharmacy Deserts Also Face Social Vulnerability, Lack of Health Care Providers
- What’s Your Cold and Flu Fighting Style?
- Understanding Your Access to Care with the Department of Veterans…
- Eggs Are Some of the Most Cost-Efficient Protein Sources. Here Are 10…
- Substantial Disparities Seen in Cancer Cases, Deaths Among Men
- Embracing Indigenous Foods to Preserve Culture and Restore Health
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions